Matches in SemOpenAlex for { <https://semopenalex.org/work/W1528589050> ?p ?o ?g. }
- W1528589050 endingPage "209" @default.
- W1528589050 startingPage "203" @default.
- W1528589050 abstract "Chronic GVHD (cGVHD) is an important problem after allotransplants. Some risk factors for cGVHD are similar to those of acute GVHD (aGVHD) but others are distinct indicating sometimes overlapping but unique pathogeneses. Precise incidence and prevalence data of cGVHD are lacking because of diverse diagnostic criteria but a 50% risk is a reasonable estimate. Incidence and prevalence of cGVHD are probably growing because of increased use of unrelated donors, blood rather than bone marrow (BM) grafts, decreased early transplant-related mortality (TRM) and increasing frequency of allotransplants. Pathophysiology of cGVHD is complex and poorly understood. Notably, no reliable surrogate end point to predict mechanism(s) of cGVHD has been identified. Therapy of cGVHD is unsatisfactory. Corticosteroids are effective but other drugs are controversial and few are rigorously tested in randomized trials. Highly variable response rates are reported because of small sample sizes and inconsistencies in eligibility, diagnostic and response criteria. We focus on the possible role of immunomodulatory drugs (IMiDs), thalidomide lenalidomide and pomalidomide, in preventing and treating cGVHD. The data suggest activity of thalidomide but at doses not clinically practical in many instances. There are few data with lenalidomide. Trials of pomalidomide, which has immune activities like thalidomide but with fewer adverse effects, are beginning. Because cGVHD is not recently reviewed in Bone Marrow Transplantation, we give a brief background and discuss challenges in diagnosing, understanding and treating cGVHD including the recently proposed National Institutes of Health consensus criteria for cGVHD." @default.
- W1528589050 created "2016-06-24" @default.
- W1528589050 creator A5005446862 @default.
- W1528589050 creator A5065897197 @default.
- W1528589050 creator A5088486180 @default.
- W1528589050 date "2012-05-14" @default.
- W1528589050 modified "2023-10-18" @default.
- W1528589050 title "Chronic GVHD: Where are we? Where do we want to be? Will immunomodulatory drugs help?" @default.
- W1528589050 cites W1512261733 @default.
- W1528589050 cites W182648912 @default.
- W1528589050 cites W1963678500 @default.
- W1528589050 cites W1966163786 @default.
- W1528589050 cites W1973532909 @default.
- W1528589050 cites W1975916512 @default.
- W1528589050 cites W1982914579 @default.
- W1528589050 cites W1985088435 @default.
- W1528589050 cites W1987528721 @default.
- W1528589050 cites W2005604237 @default.
- W1528589050 cites W2009082613 @default.
- W1528589050 cites W2009638683 @default.
- W1528589050 cites W2012553002 @default.
- W1528589050 cites W2014326468 @default.
- W1528589050 cites W2020883678 @default.
- W1528589050 cites W2025656486 @default.
- W1528589050 cites W2028590977 @default.
- W1528589050 cites W2031549987 @default.
- W1528589050 cites W2032088650 @default.
- W1528589050 cites W2036749000 @default.
- W1528589050 cites W2036872637 @default.
- W1528589050 cites W2037643196 @default.
- W1528589050 cites W2038122254 @default.
- W1528589050 cites W2043674561 @default.
- W1528589050 cites W2044560944 @default.
- W1528589050 cites W2044823845 @default.
- W1528589050 cites W2045216488 @default.
- W1528589050 cites W2048599551 @default.
- W1528589050 cites W2053677290 @default.
- W1528589050 cites W2055313377 @default.
- W1528589050 cites W2056579048 @default.
- W1528589050 cites W2056837820 @default.
- W1528589050 cites W2057638966 @default.
- W1528589050 cites W2061061720 @default.
- W1528589050 cites W2062576298 @default.
- W1528589050 cites W2063166754 @default.
- W1528589050 cites W2063805578 @default.
- W1528589050 cites W2072319661 @default.
- W1528589050 cites W2077541549 @default.
- W1528589050 cites W2077627992 @default.
- W1528589050 cites W2078016443 @default.
- W1528589050 cites W2080200044 @default.
- W1528589050 cites W2084556030 @default.
- W1528589050 cites W2086030126 @default.
- W1528589050 cites W2091496091 @default.
- W1528589050 cites W2092880198 @default.
- W1528589050 cites W2097860477 @default.
- W1528589050 cites W2099723207 @default.
- W1528589050 cites W2105604650 @default.
- W1528589050 cites W2107441545 @default.
- W1528589050 cites W2109346271 @default.
- W1528589050 cites W2110881834 @default.
- W1528589050 cites W2117768107 @default.
- W1528589050 cites W2118392817 @default.
- W1528589050 cites W2128903704 @default.
- W1528589050 cites W2129128251 @default.
- W1528589050 cites W2136669587 @default.
- W1528589050 cites W2137062141 @default.
- W1528589050 cites W2139063774 @default.
- W1528589050 cites W2139184776 @default.
- W1528589050 cites W2140143467 @default.
- W1528589050 cites W2141160379 @default.
- W1528589050 cites W2143755862 @default.
- W1528589050 cites W2143880475 @default.
- W1528589050 cites W2144828434 @default.
- W1528589050 cites W2145708130 @default.
- W1528589050 cites W2145814788 @default.
- W1528589050 cites W2149923891 @default.
- W1528589050 cites W2156177776 @default.
- W1528589050 cites W2157147843 @default.
- W1528589050 cites W2157583708 @default.
- W1528589050 cites W2161640233 @default.
- W1528589050 cites W2164703972 @default.
- W1528589050 cites W2164885965 @default.
- W1528589050 cites W2164945798 @default.
- W1528589050 cites W2316993394 @default.
- W1528589050 cites W2339981418 @default.
- W1528589050 cites W2395723318 @default.
- W1528589050 cites W2618073389 @default.
- W1528589050 cites W4232421816 @default.
- W1528589050 cites W4249086146 @default.
- W1528589050 cites W4313376856 @default.
- W1528589050 cites W4375905938 @default.
- W1528589050 doi "https://doi.org/10.1038/bmt.2012.76" @default.
- W1528589050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22580766" @default.
- W1528589050 hasPublicationYear "2012" @default.
- W1528589050 type Work @default.
- W1528589050 sameAs 1528589050 @default.
- W1528589050 citedByCount "31" @default.
- W1528589050 countsByYear W15285890502013 @default.